+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmaceutical Market in Canada 2025-2029

  • PDF Icon

    Report

  • 211 Pages
  • March 2025
  • Region: Canada
  • TechNavio
  • ID: 5949763
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical market in canada is forecasted to grow by USD 11.20 billion during 2024-2029, accelerating at a CAGR of 5% during the forecast period. The report on the pharmaceutical market in canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, increasing geriatric population in canada, and rising occurrence of chronic diseases in canada.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The pharmaceutical market in canada is segmented as below:

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies
  • Clinics
  • Direct-to-consumer

By Type

  • Prescription
  • Non-prescription

By Therapy Area

  • Oncology
  • Cardiovascular
  • Neurology
  • Endocrinology
  • Others

By Age Group

  • Adults
  • Children and adolescents
  • Geriatric

By Product Type

  • Oral drugs
  • Injectables
  • Topical drugs
  • Inhalation drugs
  • Others

By Geographical Landscape

  • North America
This study identifies the increasing advancements in biotechnology as one of the prime reasons driving the pharmaceutical market in canada growth during the next few years. Also, digital health integration in canada pharmaceutical market and heightened focus on research and development for rare diseases will lead to sizable demand in the market.

The report on the pharmaceutical market in canada covers the following areas:

  • Pharmaceutical Market in Canada sizing
  • Pharmaceutical Market in Canada forecast
  • Pharmaceutical Market in Canada industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical market in canada vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Les Laboratoires Servier, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the pharmaceutical market in canada analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Therapy Area
Executive Summary - Chart on Market Segmentation by Age Group
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada: Year-over-year growth 2024-2029 (%)
Data Table on Canada: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Pharmaceutical Market in Canada 2019 - 2023
Historic Market Size - Data Table on Pharmaceutical Market in Canada 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Therapy Area segment analysis 2019 - 2023
Historic Market Size - Therapy Area Segment 2019 - 2023 ($ million)
5.5 Age Group segment analysis 2019 - 2023
Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
5.6 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Pharmaceutical Market in Canada
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
8.4 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
8.6 Clinics - Market size and forecast 2024-2029
Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Chart on Clinics - Year-over-year growth 2024-2029 (%)
Data Table on Clinics - Year-over-year growth 2024-2029 (%)
8.7 Direct-to-consumer - Market size and forecast 2024-2029
Chart on Direct-to-consumer - Market size and forecast 2024-2029 ($ million)
Data Table on Direct-to-consumer - Market size and forecast 2024-2029 ($ million)
Chart on Direct-to-consumer - Year-over-year growth 2024-2029 (%)
Data Table on Direct-to-consumer - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Prescription - Market size and forecast 2024-2029
Chart on Prescription - Market size and forecast 2024-2029 ($ million)
Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
Chart on Prescription - Year-over-year growth 2024-2029 (%)
Data Table on Prescription - Year-over-year growth 2024-2029 (%)
9.4 Non-prescription - Market size and forecast 2024-2029
Chart on Non-prescription - Market size and forecast 2024-2029 ($ million)
Data Table on Non-prescription - Market size and forecast 2024-2029 ($ million)
Chart on Non-prescription - Year-over-year growth 2024-2029 (%)
Data Table on Non-prescription - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Therapy Area
10.1 Market segments
Chart on Therapy Area - Market share 2024-2029 (%)
Data Table on Therapy Area - Market share 2024-2029 (%)
10.2 Comparison by Therapy Area
Chart on Comparison by Therapy Area
Data Table on Comparison by Therapy Area
10.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
10.4 Cardiovascular - Market size and forecast 2024-2029
Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
10.5 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
10.6 Endocrinology - Market size and forecast 2024-2029
Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
10.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.8 Market opportunity by Therapy Area
Market opportunity by Therapy Area ($ million)
Data Table on Market opportunity by Therapy Area ($ million)
11 Market Segmentation by Age Group
11.1 Market segments
Chart on Age Group - Market share 2024-2029 (%)
Data Table on Age Group - Market share 2024-2029 (%)
11.2 Comparison by Age Group
Chart on Comparison by Age Group
Data Table on Comparison by Age Group
11.3 Adults - Market size and forecast 2024-2029
Chart on Adults - Market size and forecast 2024-2029 ($ million)
Data Table on Adults - Market size and forecast 2024-2029 ($ million)
Chart on Adults - Year-over-year growth 2024-2029 (%)
Data Table on Adults - Year-over-year growth 2024-2029 (%)
11.4 Children and adolescents - Market size and forecast 2024-2029
Chart on Children and adolescents - Market size and forecast 2024-2029 ($ million)
Data Table on Children and adolescents - Market size and forecast 2024-2029 ($ million)
Chart on Children and adolescents - Year-over-year growth 2024-2029 (%)
Data Table on Children and adolescents - Year-over-year growth 2024-2029 (%)
11.5 Geriatric - Market size and forecast 2024-2029
Chart on Geriatric - Market size and forecast 2024-2029 ($ million)
Data Table on Geriatric - Market size and forecast 2024-2029 ($ million)
Chart on Geriatric - Year-over-year growth 2024-2029 (%)
Data Table on Geriatric - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by Age Group
Market opportunity by Age Group ($ million)
Data Table on Market opportunity by Age Group ($ million)
12 Market Segmentation by Product Type
12.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
12.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
12.3 Oral drugs - Market size and forecast 2024-2029
Chart on Oral drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Oral drugs - Market size and forecast 2024-2029 ($ million)
Chart on Oral drugs - Year-over-year growth 2024-2029 (%)
Data Table on Oral drugs - Year-over-year growth 2024-2029 (%)
12.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
12.5 Topical drugs - Market size and forecast 2024-2029
Chart on Topical drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Topical drugs - Market size and forecast 2024-2029 ($ million)
Chart on Topical drugs - Year-over-year growth 2024-2029 (%)
Data Table on Topical drugs - Year-over-year growth 2024-2029 (%)
12.6 Inhalation drugs - Market size and forecast 2024-2029
Chart on Inhalation drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Inhalation drugs - Market size and forecast 2024-2029 ($ million)
Chart on Inhalation drugs - Year-over-year growth 2024-2029 (%)
Data Table on Inhalation drugs - Year-over-year growth 2024-2029 (%)
12.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
12.8 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
13 Customer Landscape
13.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
SWOT
16.5 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
16.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
16.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
16.9 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
16.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
16.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
16.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
16.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
16.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
16.18 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits 7: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits 8: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2024 and 2029
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value chain analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 21: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Chart on Canada: Year-over-year growth 2024-2029 (%)
Exhibits 23: Data Table on Canada: Year-over-year growth 2024-2029 (%)
Exhibits 24: Historic Market Size - Data Table on Pharmaceutical Market in Canada 2019 - 2023 ($ million)
Exhibits 25: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Therapy Area Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits 30: Five forces analysis - Comparison between 2024 and 2029
Exhibits 31: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 32: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 36: Chart on Market condition - Five forces 2024 and 2029
Exhibits 37: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 38: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 39: Chart on Comparison by Distribution Channel
Exhibits 40: Data Table on Comparison by Distribution Channel
Exhibits 41: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 44: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 45: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 48: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 49: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 52: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 53: Chart on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Data Table on Clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits 56: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits 57: Chart on Direct-to-consumer - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Data Table on Direct-to-consumer - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Chart on Direct-to-consumer - Year-over-year growth 2024-2029 (%)
Exhibits 60: Data Table on Direct-to-consumer - Year-over-year growth 2024-2029 (%)
Exhibits 61: Market opportunity by Distribution Channel ($ million)
Exhibits 62: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 63: Chart on Type - Market share 2024-2029 (%)
Exhibits 64: Data Table on Type - Market share 2024-2029 (%)
Exhibits 65: Chart on Comparison by Type
Exhibits 66: Data Table on Comparison by Type
Exhibits 67: Chart on Prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Data Table on Prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Chart on Prescription - Year-over-year growth 2024-2029 (%)
Exhibits 70: Data Table on Prescription - Year-over-year growth 2024-2029 (%)
Exhibits 71: Chart on Non-prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Data Table on Non-prescription - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Chart on Non-prescription - Year-over-year growth 2024-2029 (%)
Exhibits 74: Data Table on Non-prescription - Year-over-year growth 2024-2029 (%)
Exhibits 75: Market opportunity by Type ($ million)
Exhibits 76: Data Table on Market opportunity by Type ($ million)
Exhibits 77: Chart on Therapy Area - Market share 2024-2029 (%)
Exhibits 78: Data Table on Therapy Area - Market share 2024-2029 (%)
Exhibits 79: Chart on Comparison by Therapy Area
Exhibits 80: Data Table on Comparison by Therapy Area
Exhibits 81: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 84: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 85: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 88: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 89: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 101: Market opportunity by Therapy Area ($ million)
Exhibits 102: Data Table on Market opportunity by Therapy Area ($ million)
Exhibits 103: Chart on Age Group - Market share 2024-2029 (%)
Exhibits 104: Data Table on Age Group - Market share 2024-2029 (%)
Exhibits 105: Chart on Comparison by Age Group
Exhibits 106: Data Table on Comparison by Age Group
Exhibits 107: Chart on Adults - Market size and forecast 2024-2029 ($ million)
Exhibits 108: Data Table on Adults - Market size and forecast 2024-2029 ($ million)
Exhibits 109: Chart on Adults - Year-over-year growth 2024-2029 (%)
Exhibits 110: Data Table on Adults - Year-over-year growth 2024-2029 (%)
Exhibits 111: Chart on Children and adolescents - Market size and forecast 2024-2029 ($ million)
Exhibits 112: Data Table on Children and adolescents - Market size and forecast 2024-2029 ($ million)
Exhibits 113: Chart on Children and adolescents - Year-over-year growth 2024-2029 (%)
Exhibits 114: Data Table on Children and adolescents - Year-over-year growth 2024-2029 (%)
Exhibits 115: Chart on Geriatric - Market size and forecast 2024-2029 ($ million)
Exhibits 116: Data Table on Geriatric - Market size and forecast 2024-2029 ($ million)
Exhibits 117: Chart on Geriatric - Year-over-year growth 2024-2029 (%)
Exhibits 118: Data Table on Geriatric - Year-over-year growth 2024-2029 (%)
Exhibits 119: Market opportunity by Age Group ($ million)
Exhibits 120: Data Table on Market opportunity by Age Group ($ million)
Exhibits 121: Chart on Product Type - Market share 2024-2029 (%)
Exhibits 122: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits 123: Chart on Comparison by Product Type
Exhibits 124: Data Table on Comparison by Product Type
Exhibits 125: Chart on Oral drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Oral drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Oral drugs - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Oral drugs - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Topical drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Topical drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Topical drugs - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Topical drugs - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Inhalation drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Inhalation drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Inhalation drugs - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Inhalation drugs - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 145: Market opportunity by Product Type ($ million)
Exhibits 146: Data Table on Market opportunity by Product Type ($ million)
Exhibits 147: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 148: Impact of drivers and challenges in 2024 and 2029
Exhibits 149: Overview on criticality of inputs and factors of differentiation
Exhibits 150: Overview on factors of disruption
Exhibits 151: Impact of key risks on business
Exhibits 152: Companies covered
Exhibits 153: Company ranking index
Exhibits 154: Matrix on companies position and classification
Exhibits 155: Abbott Laboratories - Overview
Exhibits 156: Abbott Laboratories - Business segments
Exhibits 157: Abbott Laboratories - Key news
Exhibits 158: Abbott Laboratories - Key offerings
Exhibits 159: Abbott Laboratories - Segment focus
Exhibits 160: SWOT
Exhibits 161: AbbVie Inc. - Overview
Exhibits 162: AbbVie Inc. - Product / Service
Exhibits 163: AbbVie Inc. - Key news
Exhibits 164: AbbVie Inc. - Key offerings
Exhibits 165: SWOT
Exhibits 166: AstraZeneca Plc - Overview
Exhibits 167: AstraZeneca Plc - Product / Service
Exhibits 168: AstraZeneca Plc - Key news
Exhibits 169: AstraZeneca Plc - Key offerings
Exhibits 170: SWOT
Exhibits 171: Bayer AG - Overview
Exhibits 172: Bayer AG - Business segments
Exhibits 173: Bayer AG - Key news
Exhibits 174: Bayer AG - Key offerings
Exhibits 175: Bayer AG - Segment focus
Exhibits 176: SWOT
Exhibits 177: Boehringer Ingelheim International GmbH - Overview
Exhibits 178: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 179: Boehringer Ingelheim International GmbH - Key news
Exhibits 180: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 181: SWOT
Exhibits 182: Bristol Myers Squibb Co. - Overview
Exhibits 183: Bristol Myers Squibb Co. - Product / Service
Exhibits 184: Bristol Myers Squibb Co. - Key news
Exhibits 185: Bristol Myers Squibb Co. - Key offerings
Exhibits 186: SWOT
Exhibits 187: Eli Lilly and Co. - Overview
Exhibits 188: Eli Lilly and Co. - Product / Service
Exhibits 189: Eli Lilly and Co. - Key offerings
Exhibits 190: SWOT
Exhibits 191: F. Hoffmann La Roche Ltd. - Overview
Exhibits 192: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 193: F. Hoffmann La Roche Ltd. - Key news
Exhibits 194: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 195: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 196: SWOT
Exhibits 197: GlaxoSmithKline Plc - Overview
Exhibits 198: GlaxoSmithKline Plc - Business segments
Exhibits 199: GlaxoSmithKline Plc - Key news
Exhibits 200: GlaxoSmithKline Plc - Key offerings
Exhibits 201: GlaxoSmithKline Plc - Segment focus
Exhibits 202: SWOT
Exhibits 203: Johnson and Johnson Services Inc. - Overview
Exhibits 204: Johnson and Johnson Services Inc. - Business segments

Executive Summary

The following companies are recognized as the key players in the pharmaceutical market in canada: Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Les Laboratoires Servier, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing advancements in biotechnology."

According to the report, one of the major drivers for this market is the high investment in pharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • Apotex Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Les Laboratoires Servier
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.